Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study

Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study

Summary: Background: There are limited studies on treatment and survival analysis among patients with unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC) in routine practice in China. To address this gap, we conducted a prospective observational study in a cohort of patients treated at...

Full description

Bibliographic Details
Main Authors: Yuankai Shi, Xin Zhang, Gang Wu, Jianping Xu, Yong He, Dong Wang, Cheng Huang, Mingwei Chen, Ping Yu, Yan Yu, Wei Li, Qi Li, Xiaohua Hu, Jinjing Xia, Lilian Bu, Angela Yin, Yigong Zhou
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Treatment strategy
Overall survival
NSCLC
Risk factors
Prospective study
China
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606522000670

Similar Items

Similar Items